A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment.
| Image |  |
|---|---|
| Description | scientific article published on 9 December 2017 |
| Author/s |
author: Kojo Elenitoba-Johnson Megan S Lim |
| Publication date | December 9, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |